Immuneering
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Immuneering generated cash of -$48,968,634, which is less than the previous year. Cash used in financing activities reached the amount of $28,441,073 last year. Net change in cash is therefore -$13,231,069.
Cash Flow
| 2019 | -4.44M | -20.52K | 17.17M |
|---|---|---|---|
| 2020 | -14.62M | -53.41K | 37.98M |
| 2021 | -30.85M | -75.61M | 144.26M |
| 2022 | -44.10M | 41.83M | 19.00K |
| 2023 | -48.96M | 7.29M | 28.44M |
IMRX Cash Flow Statement (2019 โ 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 72.63M | 74.88M | 37.09M | 13.78M | 1.07M |
Operating activities | |||||
Net income | -53.47M | -50.51M | -33.53M | -17.03M | -7.70M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 352.08K | 796.79K | 159.07K | 79.30K | 18.07K |
Stock-based compensation expense | 5.72M | 4.06M | 1.80M | 1.08M | 596.63K |
| Deferred income tax benefit | 5.72M | 4.06M | 1.80M | 1.08M | 596.63K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 12.41K | 233.62K | 279.71K | -290.17K | 614.10K |
Inventories | 0 | 0 | 0 | 0 | 17.52K |
Accounts payable | -1.10M | 1.76M | -130.39K | 1.18M | 270.49K |
Cash generated by operating activities | -48.96M | -44.10M | -30.85M | -14.62M | -4.44M |
Investing activities | |||||
Purchases Of Investments | -44.66M | -50.10M | -75.62M | 0 | 0 |
Investments In Property Plant And Equipment | -342.74K | -742.48K | -60.78K | -53.41K | -20.52K |
Acquisitions Net | 0 | -41.83M | 70.34K | 0 | 0 |
Cash generated by investing activities | 7.29M | 41.83M | -75.61M | -53.41K | -20.52K |
Financing activities | |||||
Common Stock Issued | 28.20M | 19.00K | 120.31M | 37.98M | 17.22M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 3.82M |
Cash used in financing activities | 28.44M | 19.00K | 144.26M | 37.98M | 17.17M |
Net Change In Cash | -13.23M | -2.25M | 37.79M | 23.30M | 12.70M |
Cash at end of period | 59.40M | 72.63M | 74.88M | 37.09M | 13.78M |
| Data source | Data source | Data source |